Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma

NCT00054405 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

40

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Recurrent Neuroblastoma

Interventions

BIOLOGICAL: recombinant interleukin-12
BIOLOGICAL: aldesleukin

Sponsor

National Cancer Institute (NCI)